Abstract
Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Current Respiratory Medicine Reviews
Title:Recent Advances in Asthma Genetics and Antiasthma Therapy
Volume: 9 Issue: 4
Author(s): Daizee Talukdar, Narender Chaudhry, Rohit Sharma, Raman Kumar and Tapan K. Mukherjee
Affiliation:
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Abstract: Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Export Options
About this article
Cite this article as:
Talukdar Daizee, Chaudhry Narender, Sharma Rohit, Kumar Raman and Mukherjee K. Tapan, Recent Advances in Asthma Genetics and Antiasthma Therapy, Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X09666131217002352
DOI https://dx.doi.org/10.2174/1573398X09666131217002352 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclooxygenase Inhibitors: Instrumental Drugs to Understand Cardiovascular Homeostasis and Arterial Thrombosis
Cardiovascular & Hematological Disorders-Drug Targets Inhalational Anesthetics in Acute Severe Asthma
Current Drug Targets Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout
Infectious Disorders - Drug Targets Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Gastrointestinal Motility and Acute Toxicity of Pistagremic Acid Isolated from the Galls of Pistacia integerrima
Medicinal Chemistry Drug-Induced Hypokalaemia
Current Drug Safety Clinical Evaluation of Exertional Dyspnea in Adult Pectus Excavatum Patients
Current Respiratory Medicine Reviews Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Antioxidant Properties of Kalanchoe blossfeldiana – A Focus on Erythrocyte Membrane Stability and Cytoprotection
Current Traditional Medicine Inflammatory Cellular Phenotypes and Molecular Mechanisms of Glucocorticoid Resistance in Patients with Bronchial Asthma
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase
Current Drug Targets Possible Therapies of Septic Shock: Based on Animal Studies and Clinical Trials
Current Pharmaceutical Design Genetic Predictors of Drug Hypersensitivity
Current Pharmaceutical Design Cysteinyl Leukotrienes (CysLTs): Role in Obesity-Induced Asthma
Current Molecular Medicine Evaluation of the <i>In Vivo</i> Acute Toxicity and <i>In Vitro</i> Hemolytic and Immunomodulatory Activities of the <i>Moringa oleifera</i> Flower Trypsin Inhibitor (MoFTI)
Protein & Peptide Letters Receptor Guided 3D-QSAR Analysis of Thieno[2,3-b]Pyridine-5- Carbonitrile Inhibitors of Protein Kinase C Theta (PKC-θ )
Combinatorial Chemistry & High Throughput Screening Role of T Lymphocytes in the Development of Rheumatoid Arthritis. Implications for Treatment
Current Pharmaceutical Design Safety of the Thrombopoiesis-Stimulating Agents for the Treatment of Immune Thrombocytopenia
Current Drug Safety Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry